Cargando…
Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis
Cholesterol has been reported to be accumulated in cancer cells. The metabolic dysregulation of the cholesterol is associated with tumor development and progression. The cholesterol-lowering drugs have been found to be involved in the prevention and treatment of various cancers. Akt, a serine/threon...
Autores principales: | Kumar, Navneet, Mandal, Chandi C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483559/ https://www.ncbi.nlm.nih.gov/pubmed/34603386 http://dx.doi.org/10.3389/fgene.2021.724149 |
Ejemplares similares
-
High Cholesterol Deteriorates Bone Health: New Insights into Molecular Mechanisms
por: Mandal, Chandi C.
Publicado: (2015) -
Editorial: Cholesterol and cancer drug resistance: Molecular, signaling, and therapeutic aspects
por: Kaur, Mandeep, et al.
Publicado: (2022) -
Metformin exhibited anticancer activity by lowering cellular cholesterol content in breast cancer cells
por: Sharma, Ankit, et al.
Publicado: (2019) -
Zearalenone Exposure Enhanced the Expression of Tumorigenesis Genes in Donkey Granulosa Cells via the PTEN/PI3K/AKT Signaling Pathway
por: Zhang, Guo-Liang, et al.
Publicado: (2018) -
Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions
por: Laka, Kagiso, et al.
Publicado: (2022)